August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Daniel Jones: I had the privilege of attending ASCO GI to present our team’s research
Jan 29, 2025, 14:11

Daniel Jones: I had the privilege of attending ASCO GI to present our team’s research

Daniel Jones,

“I had the privilege of attending ASCO GI to present our team’s research, led by Dr. Kyaw Thein! We were honored to have three meta-analyses accepted for presentation and publication in the Journal of Clinical Oncology.

Here are the links to our research for those interested in exploring them further.”

1. Meta-analysis of randomized controlled trials (RCTs) to evaluate the incidence of hemorrhage and venous thromboembolism (VTE) events in patients with gastrointestinal (GI) cancers treated with fruquintinib.

2. Meta-analysis of phase II/III randomized controlled trials (RCTs) to determine the incidence of hypertension and proteinuria in patients with gastrointestinal (GI) cancers treated with fruquintinib.

3. Meta-analysis of phase II/III randomized controlled trials (RCTs) to evaluate the incidence of hand-foot skin reaction (HFSR) or palmar-plantar erythrodysesthesia (PPE) syndrome in patients with gastrointestinal (GI) cancers treated with fruquintinib.

Daniel Jones: I had the privilege of attending ASCO GI to present our team’s research